Browsing by Author "0dbdd294-217d-44a1-9b34-19937a7522c0"

Now showing items 1-2 of 2

    • Abnormal liver function tests on admission are associated with increased mortality in hospitalized patients ... 
      Mendizábal, Manuel; Ridruejo, Ezequiel; Pinero, Federico; Anders, Margarita; Scapellato, José; Urzúa Manchego, Álvaro; Torre, Aldo; Díaz Ferrer, Javier; Varón, Adriana; Ruiz, Sandro; Cocozzella, Daniel; Toro, Luis; González Ballerga, Esteban; Vera Pozo, Emilia; Toledo Almonacid, Claudio; Domínguez, Alejandra; Peralta, Mirta; Conte, Damián; Ratusnu, Natalia; García, Matías; Scarpin, Aldana; Brutti, Julia; Gutiérrez Lozano, Isabel; Godolfino, Miranda; Mainardi, Vitoria; Tagle, Martín; Montes, Pedro; Grazia Venturelli, María; Bustios, Carla; Escajadillo, Nataly; Aguirre, Jonathan; Pages, Josefina; Silva, Marcello O. (Wiley, 2020)
    • Direct-acting antivirals and Hepatocellular Carcinoma: No evidence of higher wait-list progression or ... 
      Piñero, Federico; Boin, Ilka; Chagas, Aline; Quiñonez, Emilio; Marciano, Sebastián; Vilatobá, Mario; Santos, Luisa; Anders, Margarita; Hoyos Duque, Sergio; Soares Lima, Agnaldo; Menéndez, Josemaría; Padilla, Martín; Poniachik Teller, Jaime; Zapata, Rodrigo; Maraschio, Martín; Chong Menéndez, Ricardo; Muñoz, Linda; Arufe, Diego; Figueroa, Rodrigo; Mendizábal, Manuel; Hurtado Gómez, Sahara; Stucchi, Raquel; Maccali, Claudia; Vergara Sandoval, Rodrigo; Bermudez, Carla; McCormack, Lucas; Varón, Adriana; Gadano, Adrián; Mattera, Juan; Rubinstein, Fernando; Carrilho, Flair; Silva, Marcelo (Wiley, 2020)
      The association between direct-acting antivirals (DAAs) and hepatocellular carcinoma (HCC) wait-list progression or its recurrence following liver transplantation (LT) remains uncertain. We evaluated the impact of DAAs on ...